Download PDF
1 / Pages

Other users also viewed these articles

Spanish Society of Primary Care Physicians (SEMERGEN) and Spanish Working Group on Crohn¿s Disease and Ulcerative Colitis (GETECCU) survey on the management of patients with inflammatory bowel disease Daniel Ginard; Mercedes Ricote; Pilar Nos; M. Elena Pejenaute; Miquel Sans; Noelia Fontanillas; Manuel Barreiro-de Acosta; José Polo Garcia;
Gastroenterol Hepatol. 2023;46:647-56
Use of digital health tools in inflammatory bowel disease Iago Rodríguez-Lago; Beatriz Gros; Kristy Sánchez; Daniel Arumí; M. del Pilar Fortes; Ana Cábez; Francisco Mesonero Gismero;
10.1016/j.gastre.2024.502200
A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study) Diego Casas Deza; Ana Belén Julián Gomara; Eva Caudevilla Biota; Belén Beltrán; Eugeni Domènech; Ana Gutiérrez Casbas; Miriam Mañosa; Yamile Zabana; Lourdes Roc Alfaro; Emilio Valverde Romero; Elena García González; Beatriz Sicilia; Viviana Laredo; Maria José Alcalá Escriche; Lucia Madero Velázquez; Rocío Ferreiro-Iglesias; Antonia Palmero Pérez; Margalida Calafat; Saioa Rubio Iturria; Irene Moraleja Yudego; Yolanda Ber Nieto; Sandra García Mateo; Javier P. Gisbert; Raquel Vicente Lidón; Lara Arias; Erika Alfambra; Ana Belén Doñate Borao; Elena Peña González; Pilar Corsino Roche; Miren Vicuña Arregui; Ainara Elorza; Manuel Domínguez Cajal; María Chaparro; Manuel Barreiro-de Acosta; Santiago García-López;
Gastroenterol Hepatol. 2024;47:821-33